
How High Can SharkNinja Stock Go?
If you know popular consumer appliance brands Shark and Ninja,…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
Income Statement | ||||||
Revenue | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Operating Income | -$1.7M | -$2.2M | -$1.7M | -$519.6K | -$414.8K | |
EBITDA | -$1.7M | -$2.3M | -$1.4M | -$480.8K | -$363.2K | |
Diluted EPS | -$0.07 | -$0.09 | -$0.06 | -$0.02 | -$0.02 |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | $17.9K | $19.6K | $155.5K | $216.8K | $664.9K | |
Total Assets | $17.9K | $3.2M | $3.3M | $3.4M | $3.2M | |
Current Liabilities | $189K | $1.9M | $2.5M | $4.2M | $4.8M | |
Total Liabilities | $189K | $1.9M | $2.5M | $4.5M | $6.5M | |
Total Equity | -$171.1K | $1.3M | $773.9K | -$1.1M | -$3.4M | |
Total Debt | -- | -- | -- | -- | -- |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
Cash Flow Statement | ||||||
Cash Flow Operations | -$1.1M | -$527.4K | -$1.4M | -$292.7K | -$206.9K | |
Cash From Investing | -$1.6K | -- | -- | -- | -- | |
Cash From Financing | $1.3M | $480K | $1.4M | $385K | $145K | |
Free Cash Flow | -$1.1M | -$527.4K | -$1.4M | -$292.7K | -$206.9K |
Next-ChemX Corp owns a Novel Membrane-Based Ion Extraction Technology called NCX technology, that economically extracts ions from solutions that are in very low concentrations. The company's extraction technology allows a continuous transfer without high pressure, temperature, or electrolysis as it mimics biological processes found in nature. The company is developing commercial pilot plant systems in its laboratory for a wide range of extraction applications that it intends to market Internationally.
In the current month, CHMX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CHMX average analyst price target in the past 3 months is --.
According to analysts, the consensus estimate is that Next-ChemX share price will drop to -- per share over the next 12 months.
Analysts are divided on their view about Next-ChemX share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Next-ChemX is a Sell and believe this share price will rise from its current level to --.
The price target for Next-ChemX over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Next-ChemX is a --. 0 of 0 analysts rate the stock a -- at this time.
You can purchase shares of Next-ChemX via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Next-ChemX shares.
Next-ChemX was last trading at $5.25 per share. This represents the most recent stock quote for Next-ChemX. Yesterday, Next-ChemX closed at $5.15 per share.
In order to purchase Next-ChemX stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
If you know popular consumer appliance brands Shark and Ninja,…
Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…
If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…
Market Cap: $4T
P/E Ratio: 56x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 34x
Veritex Holdings [VBTX] is down 3.26% over the past day.
Monopar Therapeutics [MNPR] is down 8.6% over the past day.
Nebius Group NV [NBIS] is up 2.98% over the past day.